Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | USP5 | P45974 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13773412 | 0.85 | CA12 (0.49) | CA12CA1CA2CA7HPGD | |
| Hydrochloric Acid SCHEMBL5776301 | 0.84 | HPGD (0.53) | CA12CA1CA2CA7HPGD | |
| SCHEMBL5692310 | 0.83 | ALDH1A1 (0.44) | CA12CA1CA2HPGDSMN1; SMN2 | |
| SCHEMBL4409854 | 0.83 | KIF11 (0.54) | CA12CA1CA2CA7HPGD | |
| SCHEMBL19501377 | 0.81 | CA12 (0.53) | CA12CA1CA2CA7HPGD | |
| SCHEMBL133676 | 0.81 | HPGD (0.54) | CA12CA1CA2CA7HPGD | |
| SCHEMBL9112981 | 0.81 | ACP3 (0.37) | CA12CA1CA2CA7HPGD | |
| SCHEMBL13531978 | 0.80 | CA12 (0.46) | CA12CA1CA2CA7HPGD | |
| SCHEMBL11957885 | 0.79 | SMN1; SMN2 (0.46) | CA12CA1CA2CA7HPGD | |
| SCHEMBL9564259 | 0.79 | ALDH1A1 (0.37) | CA12CA1CA2HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024030977-A2 | NOVEL MELANOCORTIN ANALOGS | SIGHTSTREAM BIOTHERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| CN-113480485-B | 1,2, 4-triaryl-1, 2, 4-triazoles compound and synthetic method thereof | 甘肃农业大学 | 2023-04-07 | — | — | CN | claimed |
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC. | 2015-06-18 | — | — | US | claimed |
| EP-2850095-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA Pharmaceuticals, Inc. (US) | 2015-03-25 | — | — | EP | claimed |
| WO-2013172954-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC (US) | 2013-11-21 | — | — | WO | claimed |
| US-20030143664-A1 | Products of manufacture and processes for peptide synthesis | DIVERSA CORPORATION (US) | 2003-07-31 | — | — | US | claimed |
| WO-2003048189-A2 | PRODUCTS OF MANUFACTURE AND PROCESSES FOR PEPTIDE SYNTHESIS | DIVERSA CORPORATION (US) | 2003-06-12 | — | — | WO | claimed |
| US-12617818-B2 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | UNIVERSITY OF NORTH TEXAS (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260116948-A1 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | BIONTECH US INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115288-A1 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | BIONTECH US INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4727654-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4729094-A2 | Modulators of complement activity | UCB Holdings, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4727653-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-5508384-A | NEUROLEPTIC AGENTS WITH REDUCED SIDE EFFECTS | NEW YORK UNIVERSITY (US) | 1996-04-16 | — | — | US | disclosed |
| WO-1995022561-A2 | PEPTIDES RECOGNIZED BY MELANOMA-SPECIFIC CYTOTOXIC LYMPHOCYTES, AND USES THEREFOR | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1995-08-24 | — | — | WO | disclosed |
| WO-1995020397-A1 | PHOSPHACAN, NUCLEIC ACIDS ENCODING THEREOF AND ANTIBODIES THERETO | NEW YORK UNIVERSITY (US) | 1995-08-03 | — | — | WO | disclosed |
| WO-1995013828-A1 | BENEFICIAL WOUND HEALING APPLICATIONS OF CALRETICULIN AND OTHER HYALURONAN-ASSOCIATED PROTEINS | NEW YORK UNIVERSITY (US) | 1995-05-26 | — | — | WO | disclosed |
| WO-1995013291-A1 | NEURON-GLIA CELL ADHESION MOLECULE, NG-CAM, IN TREATMENT OF NERVE DAMAGE | NEW YORK UNIVERSITY (US) | 1995-05-18 | — | — | WO | disclosed |
| WO-1994003601-A9 | CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN | — | 1994-03-31 | — | — | WO | disclosed |
| WO-1994003601-A2 | CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN | NEW YORK UNIVERSITY (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115288-A1 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | CD14, CD4, IL2RA | CA12 3617/4885CA1 4189/4885CA2 4480/4885 |
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | KLKB1, KLK1, KLK5 | CA12 1373/4885CA1 1427/4885CA2 2333/4885 |
| US-12617818-B2 | Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them | MYLK2, TNNC1, MYOF | CA12 3526/4885CA1 3702/4885CA2 1762/4885 |
| US-20260116948-A1 | T CELL RECEPTOR CONSTRUCTS AND USES THEREOF | MICA, IGSF11, IGLV6-57 | CA12 4663/4885CA1 4602/4885CA2 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.